Current filters:


7877 to 7886 of 96597 results

Israel'sTeva beats expectations with 40% leap in profit


Israel-headquartered Teva Pharmaceutical Industries (Nasdaq: TEVA) has reported a robust set of first-quarter…

CephalonFinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

Exec appointments at Novo Nordisk and Teva


Danish insulin giant Novo Nordisk (NOV: N) says that former Pfizer executive Robert Clark will be joining…

GenericsManagementNovo NordiskPharmaceuticalTeva Pharmaceutical Industries

Elelyso: a new therapeutic option for patients with Gaucher disease


The US Food and Drug Administration recently approved Protalix BioTherapeutic's (NYSE-AMEX: OLX) Elelyso…

CerezymeElelysoGenzymeMarkets & MarketingPfizerPharmaceuticalProtalix BioTherapeuticsRare diseasesShireVpriv

Concerns over drug resistance in Gram-negative infections has led to changes in drug usage in USA


Piperacillin-tazobactam is a leading and preferred therapy for Gram-negative infections (GNIs), accounting…

Antibiotics and Infectious diseasesMarkets & MarketingNorth AmericaPharmaceutical

GlaxoSmithKline goes on attack over Human Genome bid


UK pharma giant GlaxoSmithKline (LSE: GSK) went into attack mode this morning, taking its unsolicited…

BiotechnologyGlaxoSmithKlineHuman Genome SciencesMarkets & MarketingPharmaceutical

Santen to co-promote Bayer and Regeneron's Eylea in Japan


German drug major Bayer's (BAYN: DE) Japanese subsidiary, Bayer Yakuhin, and Santen Pharmaceutical (TYO:…

Asia-PacificBayerEyleaLicensingMarkets & MarketingOphthalmicsPharmaceuticalRegeneronSanten Pharmaceuticals

7877 to 7886 of 96597 results

Back to top